Identifying the in vivo cellular correlates of antipsychotic drugs
Preprint
Abstract
The pattern of brain activity that leads to the behavioural effects of antipsychotics is poorly understood. GPCRs such as 5-HT2A and D2 are implicated in the therapeutic and the side effects of antipsychotics. However, how these GPCRs regulate the antipsychotic-induced pattern of activities is not clearly elucidated. To address this question we used the FosTRAP mice, which can identify cells that have c-fos promoter activated. We observed that antipsychotics such as Clozapine and Olanzapine cause induction of c-fos in a number of cells in multiple cortical brain regions e.g., orbital cortex, piriform cortex. Curiously, we also identified ependymal cells as a novel cellular target of these antipsychotics. Furthermore, to determine the role of 5-HT2A in the observed pattern of activity, we combined the FosTRAP mice with the 5-HT2A knockout mice. Interestingly, the absence of 5-HT2A did not significantly affect the number of c-fos induced cells in the cortical regions. The ependymal cells, however, showed a dramatically reduced response to Clozapine in the 5-HT2A knockout mice. In summary, the TRAP system has allowed us to identify novel brain areas and region-specific cell types as the targets of antipsychotics. In addition, these results serve as a proof of principle study that can be extended to explore the biochemical and physiological changes brought about by antipsychotics and specifically identify antipsychotic-responsive cells in a live tissue.Keywords
All Related Versions
- Published version: eneuro, 5 (5).
This publication has 65 references indexed in Scilit:
- Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjectsEuropean Neuropsychopharmacology, 2013
- Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic DrugsCell, 2011
- Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In VivoThe Journal of Pharmacology and Experimental Therapeutics, 2011
- The 5-HT2A Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal GlutamateFrontiers in Systems Neuroscience, 2011
- The Presynaptic Component of the Serotonergic System is Required for Clozapine's EfficacyNeuropsychopharmacology, 2010
- Orbitofrontal Contributions to Human Working MemoryCerebral Cortex, 2010
- Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and NeuropathologySchizophrenia Bulletin, 2008
- Identification of a serotonin/glutamate receptor complex implicated in psychosisNature, 2008
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet studyLife Sciences, 1995
- The ependyma: A protective barrier between brain and cerebrospinal fluidGlia, 1995